Tilray Brands (TLRY) EBITDA Margin (QoQ) (2017 - 2026)
Tilray Brands (TLRY) EBITDA Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.34 Bn | 43.37 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.80 Bn | 40.14 Bn | 2.15 Bn |
| 3 | Zoetis | 32.38 Bn | 30.70 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.94 Bn | 18.06 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.61 Bn | 15.22 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.01 Bn | 11.48 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Tilray Brands | 538.47 Mn | 303.84 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 692.00 |
| Feb 28, 2026 | -252.00 |
| Nov 30, 2025 | -1,124.00 |
| Aug 31, 2025 | 64,410.00 |
| May 31, 2025 | -23,405.00 |
| Feb 28, 2025 | -38,904.00 |
| Nov 30, 2024 | -173.00 |
| Aug 31, 2024 | -1,109.00 |
| May 31, 2024 | 3,640.00 |
| Feb 29, 2024 | -2,204.00 |
| Nov 30, 2023 | -213.00 |
| Aug 31, 2023 | 2,943.00 |
| May 31, 2023 | 78,001.00 |
| Feb 28, 2023 | -79,293.00 |
| Nov 30, 2022 | -2,211.00 |
| Aug 31, 2022 | 29,103.00 |
| May 31, 2022 | -29,295.00 |
| Feb 28, 2022 | 2,388.00 |
| Nov 30, 2021 | 550.00 |
| Aug 31, 2021 | 1,052.00 |